TM
Treace Medical Concepts, Inc.
TMCI · NASDAQ
$4.50 -1.10% (-$0.05)
1M -2.17%
Market Cap $294.5M
P/E Ratio -
Div. Yield -
ROE 74.06%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
70 /100
Cheap P/B 4.35x
P/S 1.43x
EV/FFO N/A
Growth
87 /100
Growing Book val. growth 13.00%
Rev. growth 14.46%
FCF growth N/A
Profitability
20 /100
Weak Net margin 28.99%
Op. margin 26.17%
FCF margin 12.20%
Quality
14 /100
Poor ROE 74.06%
ROA 32.87%
Asset turnover 1.13x
Debt
45 /100
Moderate Current ratio 2.90x
Int. coverage -9.23x
Debt/Equity 1.07x
Stability
62 /100
Moderate Rev. volatility 15.42%
EPS volatility 4.06%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TMCI
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
John T. Treace
Employees
450
Headquarters
Ponte Vedra
Upcoming events
05 NOV
Earnings
Upcoming earnings report